Dr Hugh Leslie MD Longevity Medicine
Signal Separating useful health information from hype, marketing and weak evidence. 8 min read

Biological Age Testing — Useful Signal or Marketing Noise?

Biological age testing has become one of the most visible parts of the longevity industry. A single number promises to tell you whether your body is ageing faster or slower than your chronological age. It is an appealing idea, especially for people who want to measure whether lifestyle, medication or supplements are making a difference.

But the appeal of a number can exceed its meaning.

Biological age tests may provide useful information in some contexts, particularly for research or longitudinal tracking. However, they are often marketed with more certainty than the science supports. Understanding their limits is essential.

Chronological Age Versus Biological Age

Chronological age is simple: the number of years since birth. Biological age is more complex. It attempts to estimate how aged the body appears based on biological markers.

This concept is reasonable. Two people of the same chronological age can have very different levels of fitness, frailty, disease burden and physiological reserve. A healthy, active 70-year-old may function better than a sedentary 55-year-old with diabetes, hypertension and poor sleep.

The challenge is not the concept. The challenge is measurement.

Ageing affects multiple systems: immune function, metabolism, vascular health, mitochondrial biology, DNA methylation, muscle, cognition, kidney function and more. No single test captures all of this.

What Do These Tests Measure?

Many biological age tests use patterns of DNA methylation. DNA methylation is a chemical modification of DNA that can influence gene expression. Certain methylation patterns change predictably with age, allowing researchers to build “epigenetic clocks”.

Other tests use blood biomarkers, physical measures, proteomics, metabolomics or composite algorithms. Some focus on age prediction. Others aim to estimate pace of ageing or disease risk.

These tools can be scientifically interesting. Some epigenetic clocks are associated with morbidity, mortality or disease risk at a population level. But population-level association does not automatically translate into individual clinical decision-making.

This distinction is crucial.

The Problem With a Single Number

A biological age result can feel precise. For example, a report might say someone’s biological age is 47.3 years. That decimal point creates an impression of accuracy.

But biological systems are noisy. Test results may vary depending on the platform, tissue sampled, algorithm used, laboratory methods and short-term physiological state. Different biological age tests may give different answers for the same person.

A single number can also hide the underlying drivers. If a result is “older” than expected, is that due to inflammation, poor sleep, insulin resistance, smoking history, acute illness, stress, medication, body composition or something else? The test may not answer that clearly.

In clinical medicine, useful tests should change management. If a test produces anxiety but does not clarify action, its value is limited.

What Might Be Useful?

Biological age testing may have value when used cautiously and longitudinally. The most useful question may not be “What is my biological age today?” but “Is my trajectory improving over time?”

Even then, interpretation needs care. A change in a biological age score may reflect real improvement, measurement variation, regression to the mean or changes in the algorithm. Testing too frequently can create noise rather than insight.

These tests may be more useful when combined with established clinical markers: blood pressure, ApoB, glucose, HbA1c, kidney function, liver function, inflammatory markers, body composition, cardiorespiratory fitness, grip strength, sleep quality and waist circumference.

A biological age score should be treated as one possible signal, not the dashboard.

Marketing Often Runs Ahead of Medicine

The longevity field attracts strong commercial interest. This creates a predictable problem: tests are sometimes sold as if they can diagnose ageing, validate a supplement stack or prove that a person has reversed ageing.

That language should be treated cautiously. Does a test that says you are 10 years younger than your biological age mean that you are going to live 10 years longer?

Ageing is not a single disease with a single diagnostic test. A lower biological age score does not guarantee lower risk. A higher score does not necessarily mean a person is in danger. These results require context.

The most concerning use is when biological age tests are used to sell expensive interventions with weak evidence. A test may generate a number, an intervention may be prescribed, and a repeat test may appear to show improvement. Without rigorous evidence, that does not prove clinical benefit.

Better Questions to Ask

Before ordering a biological age test, it is worth asking:

  • What exactly does this test measure?
  • Has it been validated against meaningful health outcomes?
  • How reproducible is it?
  • Will the result change what I do?
  • Could the same actions be justified using standard clinical measures?
  • How often should it be repeated, if at all?
  • Is the company selling both the test and the intervention?

These questions help separate useful signal from marketing noise.

What Should We Measure Instead?

For many people, more actionable measures include:

  • Blood pressure
  • ApoB and other cardiovascular risk markers
  • Glucose, insulin resistance and HbA1c where appropriate
  • Waist circumference and body composition
  • Cardiorespiratory fitness
  • Strength and functional capacity
  • Sleep quality and sleep apnoea risk
  • Alcohol intake
  • Smoking status
  • Kidney and liver function
  • Bone density where indicated
  • Cancer screening status

These may seem less glamorous than a biological age score, but they are often more directly tied to clinical action.

A person with high blood pressure, elevated ApoB, poor sleep and low muscle strength does not need a biological age test to know where to focus. The priorities are already clear.

A Balanced View

Biological age testing should not be dismissed entirely. The science is evolving, and some tools may become more clinically useful over time. In research, these measures may help assess interventions or understand ageing biology.

The problem is overinterpretation. A biological age score can be interesting without being definitive. It can be motivating without being diagnostic. It can be one data point without being the central measure of health.

Used thoughtfully, it may have a role. Used uncritically, it can distract from better-established risk factors.

The Bottom Line

Biological age testing is an interesting area of longevity science, but it is not a complete measure of health and should not be treated as a diagnosis.

The best use is cautious, contextual and secondary to more established clinical measures. A biological age score may provide signal, but it can also create noise.

For most people, the highest value work remains familiar: improve blood pressure, metabolic health, fitness, strength, sleep, nutrition, alcohol intake, smoking status and preventive screening.

Longevity medicine should be evidence-informed, not number-obsessed. The goal is not to chase a younger score. It is to improve real health, function and resilience over time.